Showing results (51-60 of 406) with videos related to

Sort By:
Pageof 41
Cancer|March 3, 2007
The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myelomaMarius Horger, Lothar Kanz, Barbara Denecke, et al.
The Journal of Rheumatology|January 17, 2012
Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestationsJoerg C Henes, Marc Schmalzing, Wichard Vogel, et al.
Clinical Rheumatology|January 12, 2013
Enteric-coated mycophenolate sodium for progressive systemic sclerosis--a prospective open-label study with CT histography for monitoring of pulmonary fibrosisJoerg C Henes, Marius Horger, Christopher Amberger, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsetsChristina Giesert, Anke Marxer, D Robert Sutherland, et al.
Deutsche Medizinische Wochenschrift (1946)|August 16, 2012
[Severe hemorrhage in a patient with metastatic colorectal cancer - case 8/2012]Melanie Orgel, Marius Horger, Ralph Kurth, et al.
Academic Radiology|December 7, 2011
Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?Daniel Spira, Katja Weisel, Harald Brodoefel, et al.
Stem Cells (Dayton, Ohio)|August 2, 2008
OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cellsJunfeng Ji, Kausalia Vijayaragavan, Marc Bosse, et al.
AJR. American Journal of Roentgenology|May 25, 2011
Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary resultsMarius Horger, Katja Weisel, Wilhelm Horger, et al.
Leukemia & Lymphoma|October 20, 2021
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignanciesFranziska Modemann, Christian Niederwieser, Katja Weisel, et al.
Cancers|August 12, 2022
COVID-19 and Adult Acute Leukemia: Our Knowledge in ProgressFranziska Modemann, Susanne Ghandili, Stefan Schmiedel, et al.
Pageof 41